Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 10 | $159,007 |
Sells | 17 | $133,114 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
06 Feb 2024 10:27 | CNSP | CNS Pharmaceuticals Inc | CLIMACO JOHN M | Chief Executive Officer | 01 Feb 2024 | Purchase | 166,666 | 0.3 | 50,000 | D |
06 Feb 2024 10:27 | CNSP | CNS Pharmaceuticals Inc | DOWNS CHRISTOPHER | Chief Financial Officer | 01 Feb 2024 | Purchase | 66,666 | 0.3 | 20,000 | D |
06 Feb 2024 10:27 | CNSP | CNS Pharmaceuticals Inc | EVANS CARL ANTHONY | Director | 01 Feb 2024 | Purchase | 33,333 | 0.3 | 10,000 | D |
06 Feb 2024 10:28 | CNSP | CNS Pharmaceuticals Inc | GUMULKA JERZY | Director | 01 Feb 2024 | Purchase | 33,333 | 0.3 | 10,000 | D |
23 Aug 2023 08:00 | CNSP | CNS Pharmaceuticals Inc | DOWNS CHRISTOPHER | Chief Financial Officer | 22 Aug 2023 | Purchase | 27,000 | 1.2658 | 34,177 | D |
16 Aug 2023 16:01 | CNSP | CNS Pharmaceuticals Inc | CLIMACO JOHN M | Chief Executive Officer | 16 Aug 2023 | Purchase | 2,750 | 1.798 | 4,944 | D |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 28 Mar 2023 | Sale | 10,000 | 1.04 | 10,400 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 24 Mar 2023 | Sale | 5,000 | 1.08 | 5,400 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 27 Mar 2023 | Sale | 5,000 | 1.09 | 5,450 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 23 Mar 2023 | Sale | 10,000 | 1.08 | 10,800 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 22 Mar 2023 | Sale | 5,000 | 1.08 | 5,400 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 21 Mar 2023 | Sale | 5,000 | 1.1 | 5,500 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 20 Mar 2023 | Sale | 5,000 | 1.08 | 5,400 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 17 Mar 2023 | Sale | 5,000 | 1.13 | 5,650 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 16 Mar 2023 | Sale | 5,000 | 1.24 | 6,200 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 15 Mar 2023 | Sale | 5,000 | 1.22 | 6,100 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 14 Mar 2023 | Sale | 5,000 | 1.35 | 6,750 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 13 Mar 2023 | Sale | 5,000 | 1.3 | 6,500 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 10 Mar 2023 | Sale | 5,000 | 1.29 | 6,450 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 09 Dec 2022 | Sale | 2,798 | 2.43 | 6,799 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 08 Dec 2022 | Sale | 5,500 | 2.4 | 13,200 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 07 Dec 2022 | Sale | 5,500 | 2.46 | 13,530 | I |
01 Aug 2023 17:10 | CNSP | CNS Pharmaceuticals Inc | PRIEBE WALDEMAR | 10% | 06 Dec 2022 | Sale | 5,500 | 2.47 | 13,585 | I |
21 Apr 2023 07:58 | CNSP | CNS Pharmaceuticals Inc | GUMULKA JERZY | Director | 19 Apr 2023 | Purchase | 2,500 | 1.7 | 4,250 | D |
18 Apr 2023 08:00 | CNSP | CNS Pharmaceuticals Inc | DOWNS CHRISTOPHER | Chief Financial Officer | 17 Apr 2023 | Purchase | 3,100 | 3.2 | 9,920 | D |
17 Apr 2023 08:17 | CNSP | CNS Pharmaceuticals Inc | GUMULKA JERZY | Director | 10 Apr 2023 | Purchase | 7,173 | 0.74 | 5,308 | D |
14 Apr 2023 16:20 | CNSP | CNS Pharmaceuticals Inc | CLIMACO JOHN M | Chief Executive Officer | 12 Apr 2023 | Purchase | 15,000 | 0.6939 | 10,408 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)